CORT

#3683
Corcept Therapeutics Incorporated - Common Stock
0.6 9 USD
-98.98%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
0.69
0.69
Year Range
0.69
89.00
Daily Change
-98.98%
Monthly Change
-98.52%
6 month change
-99.11%
Year Change
-99.05%
Previous Close
68.3 8
Open
0.6 9
Low
0.6 9
High
0.6 9
Volume
220
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

Corcept Therapeutics Incorporated - Common Stock

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.

News